Heat-directed suicide gene therapy for breast cancer

Adjuvant hyperthermia can improve treatment outcome for locally recurrent breast cancer (LRBC). Previously, we demonstrated that infection of human breast cancer cells with a recombinant adenovirus expressing β-galactosidase from the human hsp70b gene promoter (Ad.70b.βgal) results in 50- to 800-fold increases in reporter gene expression following heat treatment (30 minutes at 43°C). Here, we describe a heat-directed suicide gene therapy strategy based on an adenoviral vector (Ad.70b.CDTK) in which expression of the dual prodrug-activating E. coli cytosine deaminase/herpes simplex virus thymidine kinase (CDTK) fusion gene is under the control of the hsp70b promoter. Treatment of T47D and MCF-7 breast cancer cells with mild hyperthermia (43°C/30 minutes) and prodrugs (100 μg/ml 5-fluorocytosine and 10 μg/ml ganciclovir) following infection with Ad.70b.CDTK (10–100 PFU/cell) resulted in 30- to 60-fold decreases in clonogenic survival relative to control cultures treated with heat or prodrugs alone. Clonogenic survival declined even further (up to 240-fold) following heat treatment at 41.5°C for 120 minutes. A decreased clonogenic survival was accompanied by tumor cell apoptosis. These results demonstrate that this combined treatment strategy can be highly effective against heat- and radiation-resistant breast tumor cells and supports the continued development of heat-directed CDTK suicide gene therapy strategies for LRBC.

[1]  D. Ngo,et al.  Tumor-targeted gene therapy for nasopharyngeal carcinoma. , 2002, Cancer research.

[2]  J. H. Kim,et al.  Double suicide gene therapy augments the antitumor activity of a replication-competent lytic adenovirus through enhanced cytotoxicity and radiosensitization. , 2000, Human gene therapy.

[3]  A. Fattaey,et al.  An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells , 1996, Science.

[4]  M. Borrelli,et al.  Heat-activated transgene expression from adenovirus vectors infected into human prostate cancer cells. , 2001, Cancer research.

[5]  Y. Lee,et al.  Adenoviral-mediated transfer of a heat-inducible double suicide gene into prostate carcinoma cells. , 1998, Cancer research.

[6]  A. Takahashi,et al.  Transfection of p53-knockout mouse fibroblasts with wild-type p53 increases the thermosensitivity and stimulates apoptosis induced by heat stress. , 1997, International journal of radiation oncology, biology, physics.

[7]  R. Issels,et al.  Hyperthermia in oncology. , 2001, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[8]  M. Dewhirst,et al.  Heat-induced gene expression as a novel targeted cancer gene therapy strategy. , 2000, Cancer research.

[9]  C. Hudis,et al.  Adjuvant drug therapy for operable breast cancer. , 1996, Seminars in oncology.

[10]  J. Haveman,et al.  Inactivation of p53 and of pRb protects human colorectal carcinoma cells against hyperthermia-induced cytotoxicity and apoptosis , 1999, Journal of Cancer Research and Clinical Oncology.

[11]  Y. Pommier,et al.  Apoptotic response to camptothecin and 7‐hydroxystaurosporine (UCN‐01) in the 8 human breast cancer cell lines of the NCI anticancer drug screen: Multifactorial relationships with topoisomerase i, protein kinase C, Bcl‐2, p53, MDM‐2 and caspase pathways , 1999, International Journal of Cancer.

[12]  H. Klamut,et al.  Adenovirus-p53 gene therapy in human nasopharyngeal carcinoma xenografts. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  John J. Kim,et al.  The effects of combining ionizing radiation and adenoviral p53 therapy in nasopharyngeal carcinoma. , 1999, International journal of radiation oncology, biology, physics.

[14]  S. Freytag,et al.  Selective radiosensitization of 9L glioma in the brain transduced with double suicide fusion gene. , 1998, The cancer journal from Scientific American.

[15]  E. Gerner,et al.  Heat-inducible vectors for use in gene therapy , 2000, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[16]  T. Clackson,et al.  A system for small-molecule control of conditionally replication-competent adenoviral vectors. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[17]  G. Li,et al.  Protein glycosylation in a heat-resistant rat fibroblast cell model expressing human HSP70. , 1997, Biochemical and biophysical research communications.

[18]  S. Freytag,et al.  Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  S. Hayashi,et al.  THE EFFECTS OF COMBINED TREATMENTS WITH LOW HYPERTHERMIA AND BLEOMYCIN ON SURVIVAL OF MORINE L CELLS , 1997 .

[20]  J. Woodgett,et al.  The role of protein kinase B (PKB) in modulating heat sensitivity in a human breast cancer cell line. , 2001, International journal of radiation oncology, biology, physics.

[21]  S. Freytag,et al.  Pronounced antitumor effects and tumor radiosensitization of double suicide gene therapy. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[22]  D Machin,et al.  Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. , 1996, International journal of radiation oncology, biology, physics.

[23]  M. Clarke,et al.  A novel, conditionally replicative adenovirus for the treatment of breast cancer that allows controlled replication of E1a-deleted adenoviral vectors. , 2000, Human gene therapy.

[24]  P. Goss,et al.  Locoregionally recurrent breast cancer: incidence, risk factors and survival. , 2001, Cancer treatment reviews.

[25]  H. Kampinga,et al.  Thermal protein denaturation and protein aggregation in cells made thermotolerant by various chemicals: role of heat shock proteins. , 1995, Experimental cell research.

[26]  H. Matsumoto,et al.  Enhancement of Cell Killing by Induction of Apoptosis after Treatment with Mild Hyperthermia at 42°C and Cisplatin , 2001 .

[27]  O. Wildner,et al.  Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer , 1999, Gene Therapy.

[28]  I. H. Engels,et al.  Ionizing radiation but not anticancer drugs causes cell cycle arrest and failure to activate the mitochondrial death pathway in MCF-7 breast carcinoma cells , 2001, Oncogene.

[29]  J. Jessup,et al.  Replicating adenoviral vector–mediated transfer of a heat-inducible double suicide gene for gene therapy , 2001, Cancer Gene Therapy.

[30]  D. Brough,et al.  Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen. , 2000, The Journal of clinical investigation.

[31]  D Machin,et al.  Relationship between thermal dose and outcome in thermoradiotherapy treatments for superficial recurrences of breast cancer: data from a phase III trial Sherar, , 2004 .

[32]  Y. Li,et al.  Prostate-specific expression of the diphtheria toxin A chain (DT-A): studies of inducibility and specificity of expression of prostate-specific antigen promoter-driven DT-A adenoviral-mediated gene transfer. , 2002, Cancer research.

[33]  C. Moonen,et al.  Control of transgene expression using local hyperthermia in combination with a heat‐sensitive promoter , 2000, The journal of gene medicine.

[34]  J. Zee,et al.  © 1999 Cancer Research Campaign Article no. bjoc.1998.0075 Reirradiation combined with hyperthermia in recurrent , 2022 .

[35]  Pei-Xiang Li,et al.  Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer , 1999, Cancer Gene Therapy.

[36]  F. Graham,et al.  Adenovirus-based expression vectors and recombinant vaccines. , 1992, Biotechnology.

[37]  P. Goss,et al.  Does treatment at the time of locoregional failure of breast cancer alter prognosis? , 2001, Cancer treatment reviews.

[38]  J. H. Li,et al.  Cytotoxic effects of Ad5CMV-p53 expression in two human nasopharyngeal carcinoma cell lines. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[39]  M. Dewhirst,et al.  Enhancement of radiotherapy by hyperthermia-regulated gene therapy. , 2000, International journal of radiation oncology, biology, physics.

[40]  Y. Kaneda,et al.  Eradication of breast cancer xenografts by hyperthermic suicide gene therapy under the control of the heat shock protein promoter. , 2000, Human gene therapy.

[41]  H M Rosenberg,et al.  Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. , 2001, Journal of the National Cancer Institute.

[42]  J. Olsen,et al.  Comparison of the effects of three different toxin genes and their levels of expression on cell growth and bystander effect in lung adenocarcinoma. , 1996, Cancer research.

[43]  Pei-Xiang Li,et al.  Heat-directed gene targeting of adenoviral vectors to tumor cells , 2000, Cancer Gene Therapy.